Onxeo S.A. sell Biotechhunter
Start price
28.10.20
/
50%
€0.60
Target price
04.11.21
-
Performance (%)
1.66%
End price
15.07.21
€0.61
Summary
This prediction ended on 15.07.21 with a price of €0.61. The SELL prediction by Biotechhunter shows the price for Onxeo S.A. slightly increased by 1.66% during the runtime of the prediction. Biotechhunter has 50% into this predictionOnxeo is a cutting-edge biotechnology company that specializes in the research and development of novel drugs to treat patients with rare or resistant cancers. Headquartered in Paris, France, this innovative firm has established itself as a leader in the field by leveraging its advanced platform, known as DNA Therapeutics, in conjunction with a comprehensive portfolio of small molecules and orphan oncology assets. With a strong commitment to scientific excellence and a robust intellectual property strategy, Onxeo aims to improve patient outcomes by addressing critical unmet medical needs and creating value for stakeholders through strategic partnerships and licensing deals.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Onxeo S.A. | -13.636% | -13.636% | 81.199% | -16.771% |
| iShares Core DAX® | 0.734% | 1.458% | 17.980% | 65.292% |
| iShares Nasdaq 100 | -2.686% | -0.146% | 3.810% | 97.467% |
| iShares Nikkei 225® | -2.261% | -2.729% | 11.679% | 39.755% |
| iShares S&P 500 | -1.346% | 0.467% | 1.970% | 61.093% |
Comments by Biotechhunter for this prediction
In the thread Onxeo S.A. diskutieren
Sell Onxeo S.A.